Home
AIMD
AIMD News

Latest Ainos Inc. (AIMD) News on September 4, 2025

ACCESS Newswire

2 months ago

New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V.

MT Newswires

2 months ago

Ainos, ASE Technology to Expand AI Nose Technology in Semiconductor Facility

ACCESS Newswire

2 months ago

Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites

MT Newswires

2 months ago

Ainos Plans 1-for-5 Reverse Stock Split

ACCESS Newswire

2 months ago

Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation

ACCESS Newswire

2 months ago

Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia

ACCESS Newswire

3 months ago

Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25

ACCESS Newswire

3 months ago

Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy

ACCESS Newswire

3 months ago

Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter

Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%

ACCESS Newswire

3 months ago

Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%

Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner

ACCESS Newswire

3 months ago

Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner

ACCESS Newswire

3 months ago

AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street

ACCESS Newswire

4 months ago

Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy

ACCESS Newswire

4 months ago

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

ACCESS Newswire

4 months ago

Ainos Reports First Quarter 2025 Financial Results

ACCESS Newswire

4 months ago

Atossa Therapeutics and Ainos Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESS Newswire

4 months ago

Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

ACCESS Newswire

4 months ago

Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly

Ainos and ugo Complete First Robotic Smell Integration in Japan

ACCESS Newswire

4 months ago

Ainos and ugo Complete First Robotic Smell Integration in Japan

ACCESS Newswire

5 months ago

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

ACCESS Newswire

5 months ago

Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling

ACCESS Newswire

5 months ago

Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025

ACCESS Newswire

6 months ago

Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose’s Potential in Chip Manufacturing and More

ACCESS Newswire

6 months ago

Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing

Ainos Full Year 2024 Earnings: US$1.56 loss per share (vs US$3.36 loss in FY 2023)

Simply Wall St.

6 months ago

Ainos Full Year 2024 Earnings: US$1.56 loss per share (vs US$3.36 loss in FY 2023)

ACCESS Newswire

6 months ago

Ainos Reports Full Year 2024 Financial Results

ACCESS Newswire

6 months ago

Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

Ainos, ugo to develop robot with sense of smell

TipRanks

6 months ago

Ainos, ugo to develop robot with sense of smell

Ainos and ugo to Develop the World's First Robot With a Sense of Smell

ACCESS Newswire

6 months ago

Ainos and ugo to Develop the World's First Robot With a Sense of Smell

ACCESS Newswire

7 months ago

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

ACCESS Newswire

7 months ago

Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

ACCESS Newswire

8 months ago

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

ACCESS Newswire

8 months ago

Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

ACCESSWIRE

9 months ago

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

ACCESSWIRE

9 months ago

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

ACCESSWIRE

9 months ago

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

ACCESSWIRE

9 months ago

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

Newsfile

9 months ago

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

ACCESSWIRE

10 months ago

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

ACCESSWIRE

10 months ago

Ainos Announces IRB Approval for Sjögren’s Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Ainos Third Quarter 2024 Earnings: US$0.33 loss per share (vs US$0.73 loss in 3Q 2023)

Simply Wall St.

10 months ago

Ainos Third Quarter 2024 Earnings: US$0.33 loss per share (vs US$0.73 loss in 3Q 2023)

ACCESSWIRE

10 months ago

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

ACCESSWIRE

10 months ago

Ainos Reports Third Quarter 2024 Financial Results

ACCESSWIRE

10 months ago

Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets

ACCESSWIRE

10 months ago

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

ACCESSWIRE

a year ago

Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies

ACCESSWIRE

a year ago

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA

ACCESSWIRE

a year ago

Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome

ACCESSWIRE

a year ago

Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options

ACCESSWIRE

a year ago

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

ACCESSWIRE

a year ago

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

ACCESSWIRE

a year ago

Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention

ACCESSWIRE

a year ago

Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter

ACCESSWIRE

a year ago

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter

Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety

ACCESSWIRE

a year ago

Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety

ACCESSWIRE

a year ago

Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024

ACCESSWIRE

a year ago

Ainos Secures Exclusive Multi-Regions Invention Patent Licenses from Strategic Partner to Bolster AI Nose and Point-Of-Care Testing

Ainos Second Quarter 2024 Earnings: US$0.49 loss per share (vs US$0.58 loss in 2Q 2023)

Simply Wall St.

a year ago

Ainos Second Quarter 2024 Earnings: US$0.49 loss per share (vs US$0.58 loss in 2Q 2023)

ACCESSWIRE

a year ago

Ainos Concludes Growth Financing From Lind Partners

ACCESSWIRE

a year ago

Ainos Reports Second Quarter 2024 Financial Results

ACCESSWIRE

a year ago

Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug

ACCESSWIRE

a year ago

Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA

ACCESSWIRE

a year ago

Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market

ACCESSWIRE

a year ago

Ainos Reports First Quarter 2024 Financial Results

ACCESSWIRE

a year ago

Ainos Raises $9 Million in Growth Capital with Existing Shareholder

Ainos Full Year 2023 Earnings: US$3.36 loss per share (vs US$5.14 loss in FY 2022)

Simply Wall St.

a year ago

Ainos Full Year 2023 Earnings: US$3.36 loss per share (vs US$5.14 loss in FY 2022)

ACCESSWIRE

a year ago

Ainos Reports Full Year 2023 Financial Results

Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing

GlobeNewswire

2 years ago

Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing

Small-Cap Growth Virtual Investor Conference Agenda Announced for February 7th, 2024

GlobeNewswire

2 years ago

Small-Cap Growth Virtual Investor Conference Agenda Announced for February 7th, 2024

ACCESSWIRE

2 years ago

Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms

Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th

GlobeNewswire

2 years ago

Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th

Be Wary Of Meihua International Medical Technologies (NASDAQ:MHUA) And Its Returns On Capital

Simply Wall St.

2 years ago

Be Wary Of Meihua International Medical Technologies (NASDAQ:MHUA) And Its Returns On Capital

Two New Knightscope Security Robots Now Protecting Houston Property

Business Wire

2 years ago

Two New Knightscope Security Robots Now Protecting Houston Property

GlobeNewswire

2 years ago

Diamond Equity Research Releases Update Note on YS Biopharma Co., Ltd. (NASDAQ: YS)

ACCESSWIRE

2 years ago

Ainos Announces $1.75 Million Follow-On Funding

Newton Shafts, a Division of Sacks Parente, Announces the Signing of PGA TOUR Champions Player Ken Duke as its First Player to its Roster

GlobeNewswire

2 years ago

Newton Shafts, a Division of Sacks Parente, Announces the Signing of PGA TOUR Champions Player Ken Duke as its First Player to its Roster

Wearable Devices: The Mudra Band Featured by Leading Tech Magazines, Mashable and VentureBeat

GlobeNewswire

2 years ago

Wearable Devices: The Mudra Band Featured by Leading Tech Magazines, Mashable and VentureBeat

REE Completes U.S. Certification of Full-by-Wire Vehicles and Begins Customer Deliveries of its P7-C Electric Truck

GlobeNewswire

2 years ago

REE Completes U.S. Certification of Full-by-Wire Vehicles and Begins Customer Deliveries of its P7-C Electric Truck

Worksport Announces SOLIS Solar Truck Cover will be Available for FORD, RAM (Stellantis) & GM

GlobeNewswire

2 years ago

Worksport Announces SOLIS Solar Truck Cover will be Available for FORD, RAM (Stellantis) & GM

Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

GlobeNewswire

2 years ago

Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination

GlobeNewswire

2 years ago

Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination

Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement

GlobeNewswire

2 years ago

Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement

Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

2 years ago

Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

GlobeNewswire

2 years ago

Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

Foghorn Therapeutics Announces CFO Departure

GlobeNewswire

2 years ago

Foghorn Therapeutics Announces CFO Departure

OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC

GlobeNewswire

2 years ago

OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC

Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.

Business Wire

2 years ago

Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.

ACCESSWIRE

2 years ago

Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement

Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell

ACCESSWIRE

2 years ago

Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell

Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024

PR Newswire

2 years ago

Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024

11 Popular Penny Stocks on Robinhood

Insider Monkey

2 years ago

11 Popular Penny Stocks on Robinhood

EPOW Lead in Establishing National Battery Industry Standard Policy, Highlighting Its Position as a Benchmark in Technological Innovation, Product Quality and Management Efficiency in the Industry

GlobeNewswire

2 years ago

EPOW Lead in Establishing National Battery Industry Standard Policy, Highlighting Its Position as a Benchmark in Technological Innovation, Product Quality and Management Efficiency in the Industry

Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences

Business Wire

2 years ago

Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences

InvestorPlace

2 years ago

AMC Stock: This Dog With Fleas Just Won’t Die. Should You Buy? NO.

ACCESSWIRE

2 years ago

Ainos, Inc. Announces Stock Consolidation

11 Best Stocks to Buy for the Next 10 Years

Insider Monkey

2 years ago

11 Best Stocks to Buy for the Next 10 Years

Uxin Limited Announces Successful Validation of Superstore Business Model, Significant Reduction in Losses, and Target of Achieving Overall Profitability by 2024

PR Newswire

2 years ago

Uxin Limited Announces Successful Validation of Superstore Business Model, Significant Reduction in Losses, and Target of Achieving Overall Profitability by 2024

La Rosa Implements Final Offer to Deliver Transparency in Real Estate Transactions

GlobeNewswire

2 years ago

La Rosa Implements Final Offer to Deliver Transparency in Real Estate Transactions

Hycroft Regains Compliance with Nasdaq Listing Requirements

PR Newswire

2 years ago

Hycroft Regains Compliance with Nasdaq Listing Requirements

POET Technologies Issues Letter to Shareholders

GlobeNewswire

2 years ago

POET Technologies Issues Letter to Shareholders

Share on Social Networks: